soothing and repair hair treatment

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

The reference uses glycerin as a polyol humectant across washes, gels, and emulsions. Treat the percentage as development guidance.

3. Typical use levels (formulation guide)

• Gels and serums may use the guide range 3–8% for the formula.
• For creams, use 2–5%.
• The stated reference for rinse-off is 2–4% in this reference.

The guide places Glycerin in the water phase and calls for no melt step.

4. Regulatory sources & global compliance

• The CosIng record for Glycerin, where listed, is informational rather than product-specific authorization.
• For a cosmetic sold in the EU, Regulation (EC) No 1223/2009 requires a safety review of the finished cosmetic in which Glycerin is used rather than for an ingredient name alone.
• Establish grade-specific details for Glycerin from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

This level is a cosmetic-formulation guide; it does not qualify a finished product as a drug or OTC product so assess patch response and stability in the final formula.

6. Stability & packaging

Keep the ingredient in cool, closed bulk storage away from sunlight; if the formula is oxidation-sensitive, an airless or pump format may be considered; confirm compatibility and stability using the selected formula and pack.

7. Claims language (Do / Don’t)

• The cosmetic concept for Glycerin in this entry centers on humectant function.

• This formulation entry does not demonstrate drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The documented facts for Glycerin cannot verify whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Typical use levels (formulation guide)

• For gel-creams, use 2–6%.
• For dry oils, the reference gives 10–30% in this reference.
• The balms use-level reference is 5–15% in this reference.

Add Squalane through the oil phase; no additional wax-processing shear step is called for.

4. Regulatory sources & global compliance

• If Squalane appears in CosIng, its entry is informational and does not approve a specific grade or finished cosmetic.
• Regulation (EC) No 1223/2009 requires the complete cosmetic containing Squalane to receive its own safety assessment as part of the finished cosmetic's safety documentation.
• Use current supplier documentation for the purchased Squalane grade and verify applicable destination-market filings.

5. Safety & risk assessment

The percentage is shown for cosmetic development; no drug approval or OTC status is conferred by this entry so patch response and stability should be checked on the finished product.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; choose a package with oxidation sensitivity in view; confirm final stability and pack compatibility on a representative batch.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Squalane highlights a light-emollient role.

• This product entry does not establish drug-treatment outcomes, clinical cures, or certifications not documented for the SKU.
• The documented facts for Squalane does not substantiate skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

The butter role is assigned to shea in creams, balms, and hair creams. The reference makes no assumption about unrefined color or scent.

3. Typical use levels (formulation guide)

• Creams: 2–8% for the formula.
• Formulation guidance for balms and butters: 10–25% in this reference.

The listed method melts Butyrospermum Parkii Butter into oil and maintains shear as the blend cools to reduce graining.

4. Regulatory sources & global compliance

• If Butyrospermum Parkii Butter appears in CosIng, its entry is informational and does not approve a specific grade or finished cosmetic.
• EU market placement under Regulation (EC) No 1223/2009 requires a safety assessment covering the complete formulation with Butyrospermum Parkii Butter for the specific product as it will be marketed.
• Establish grade-specific details for Butyrospermum Parkii Butter from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it is not evidence of drug approval or OTC authorization with patch assessment and finished-formula stability testing still required.

6. Stability & packaging

Protect the sealed bulk from heat, sun, and unnecessary exposure; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; assess the confirmed formula for stability and package compatibility.

7. Claims language (Do / Don’t)

• For cosmetic use, this entry records Butyrospermum Parkii Butter in a direction centered on shea cushion.

• This ingredient reference does not establish drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• The formulation record for Butyrospermum Parkii Butter cannot verify whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.